Senior Director, GCS — Rare Endocrinology - Palsonify
Vertex Pharmaceuticals - Boston, MA
Posted Nov 15, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 17, 2026
- Verification
- Not verified
- Salary
- $240K-$360K From the posting source checked Nov 17, 2026
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 17, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 17, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Senior Director, GCS — Rare Endocrinology - Palsonify Boston, MA Job Description General Summary: The Senior Director Global Commercial Strategy (GCS), Rare Endocrinology - PALSONIFY will serve as the global commercial lead for Palsonify. Reporting to the Vice President, GCS - Rare Endocrinology, this leader will own the integrated commercial strategy for acromegaly and help translate the potential of Palsonify into a differentiated global commercialization plan. Palsonify joined the Vertex portfolio through the acquisition of Crinetics Pharmaceuticals and is currently approved and marketed in the United States and approved in the European Commission. The Senior Director will lead the global commercial market assessment for acromegaly in partnership with the international team, drive global launch preparation, shape evidence generation and publication priorities, and develop the lifecycle management strategy for Palsonify. Key Duties & Responsibilities Serve as the global commercial lead for Palsonify · Lead the commercial market assessment for acromegaly, including epidemiology, patient segmentation, unmet need, treatment patterns, patient and HCP journeys, competitive dynamics, access considerations, and global market potential. Develop and maintain the commercial strategy and target product profile for Palsonify in acromegaly, defining the patient populations, differentiation, value drivers, evidence requirements, and critical success factors required to win. Provide commercial leadership into clinical development and real-world evidence plans, ensuring populations, endpoints, comparators, and evidence generation support meaningful differentiation and commercialization objectives. Lead commercial development activities, including primary market research, forecasting, competitive intelligence, scenario planning, opportunity assessments, and investment recommendations. Leverage the US brand strategy to develop the integrated global
Read the full description at vrtx.wd501.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Medical Director, Endocrinology
Vertex Pharmaceuticals - Boston, MA
Senior Director, Global Commercial Development, Early Detection & Market Shaping
Revolution Medicines - Remote (United States)
Senior Director, Global Market Access
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Senior Director Oncology Commercial Strategy Biomarkers
Bristol Myers Squibb - Princeton - NJ - US